Noble Biomaterials Competitors, Revenue, Alternatives and Pricing

Claim your profile


Scranton, PA USA
Total Funding:$8M
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Noble Biomaterials's estimated annual revenue is currently $24.8M per year.(?)
  • Noble Biomaterials's estimated revenue per employee is $270,000
  • Noble Biomaterials's total funding is $8M.

Employee Data

  • Noble Biomaterials has 92 Employees.(?)
  • Noble Biomaterials currently has 1 job openings.

The story of Noble Biomaterials, Inc. begins at a turn-of-the-century textile mill in New York named Sauquoit. Originally a cotton spinning mill, the company eventually moved operations to Scranton, PA in 1873. There, Sauquoit functioned as a silk spinning facility and experienced rapid growth to become one of the country’s largest silk weavers. Operations continued for an entire century until the early 1900’s when the advent of man-made fibers, rayon and acetate brought a new market direction. Sauquoit adapted quickly to become a leader in processing filament yarns. The company was an early entrant into the textured yarn business going on to produce a new fiber called “Nylon®” under license of DuPont® industries. A key turning point came in 1997, as the company was sold and Noble Fiber Technologies was founded. During that time conductive fiber technology utilizing silver was created for use in industrial markets. This novel manufacturing process led to the invention of a new technology that would eventually be branded X-STATIC®. This innovative new technology was immediately explored for applications in anti-static carpeting, and in doing so, Noble Fiber Technologies began its next evolution “from silk to technology.”